Characterization of a transthyretin (prealbumin) variant associated with familial amyloidotic polyneuropathy type II (Indiana/Swiss).
about
Fibril in senile systemic amyloidosis is derived from normal transthyretinTertiary structures of amyloidogenic and non-amyloidogenic transthyretin variants: new model for amyloid fibril formationNew transthyretin mutation V28M in a Portuguese kindred with amyloid polyneuropathy.Biochemical characteristics of variant transthyretins causing hereditary leptomeningeal amyloidosis.A new transthyretin variant (Ser 24) associated with familial amyloid polyneuropathy.Iowa variant of familial Alzheimer's disease: accumulation of posttranslationally modified AbetaD23N in parenchymal and cerebrovascular amyloid depositsHereditary renal amyloidosis with a novel variant fibrinogen.Transthyretin mutations in hyperthyroxinemia and amyloid diseases.Ocular manifestations of familial amyloidotic polyneuropathy type I: long-term follow up.Identification of a new hereditary amyloidosis prealbumin variant, Tyr-77, and detection of the gene by DNA analysis.Analysis of amyloid deposition in a transgenic mouse model of homozygous familial amyloidotic polyneuropathyImmunohistochemical characterization of amyloid proteins in sural nerves and clinical associations in amyloid neuropathyCerebral amyloidosis: amyloid subunits, mutants and phenotypes.Transthyretin gene mutations in British and French patients with amyloid neuropathy.Hereditary amyloidosis--disease entity and clinical model.Gelsolin-related amyloidosis. Identification of the amyloid protein in Finnish hereditary amyloidosis as a fragment of variant gelsolin.Systemic senile amyloidosis. Identification of a new prealbumin (transthyretin) variant in cardiac tissue: immunologic and biochemical similarity to one form of familial amyloidotic polyneuropathy.Modifications of transthyretin in amyloid fibrils: analysis of amyloid from homozygous and heterozygous individuals with the Met30 mutation.CEREBRAL AMYLOID ANGIOPATHY AND ALZHEIMER'S DISEASE.Conformation-sensitive antibodies against alzheimer amyloid-beta by immunization with a thioredoxin-constrained B-cell epitope peptide.The transthyretin cDNA sequence is normal in transthyretin-derived senile systemic amyloidosis.Amyloidogenic and anti-amyloidogenic properties of recombinant transthyretin variants.Biochemical characterization of vitreous and cardiac amyloid in Ile84Ser transthyretin amyloidosis.Vitreous amyloidosis in two large mainland Chinese kindreds resulting from transthyretin variant Lys35Thr and Leu55Arg.Japanese monozygotic twins with familial amyloidotic polyneuropathy (FAP) (ATTR VaBOMet)Transthyretin (TTR)-derived amyloid fibrils: Immunoelectron microscopy of fibrils formedin vivoandin vitrofrom synthetic peptides and normal transthyretinHaplotype analysis of the transthyretin gene: Evidence for multiple recurrence of the Met30 mutation in the Caucasian populationStructural changes in transthyretin produced by the Ile 84 Ser mutation which result in decreased affinity for retinol-binding proteinProgression of cardiac amyloid deposition in hereditary transthyretin amyloidosis patients after liver transplantation
P2860
Q24558717-C7B54AC4-250E-4212-B2D2-B79E45CB6A73Q27766043-0C006F44-2BB1-4789-ADDB-726692AB8ABCQ30651190-686AD9F0-1603-418F-B0A4-A42F7C25CC52Q30805928-AEC224D1-42B9-4E31-9BAF-3F7F860960EFQ33676379-3598435A-6B9F-4244-BCA5-156A65445A0EQ33745216-A73069BD-7F76-418A-BC6E-2E7125B39EB4Q34126123-509482DB-4810-4424-B348-F2144CA9F921Q34269382-5438BB17-62A4-49A1-8A67-75538FB93615Q35299875-186E26E9-F974-4416-AA50-AFFA1767F809Q35585176-D3509580-E6A7-4AF7-8B67-020AF657F599Q35764345-C195215B-75C6-4643-A5F1-CA6E59401734Q35831830-D9CA8C36-58C7-4F6C-88D7-4B747F1D3617Q36136387-CA9BF4A6-E1AB-4E0A-BCE6-0A4418965B90Q36976959-AD03DEB4-B970-48EA-A0CE-1689B9DAF8A6Q39601205-C306162A-0102-41C4-A831-94B6647C85C5Q40340220-9506ED4E-9613-4F27-93A5-64034182D708Q40378952-18A6B386-946F-4EBB-A765-C5CDA1B17A49Q40872054-464B29B9-33F6-41C9-B790-23CD61168012Q42396970-2F2302B6-F95D-4214-97EE-503B2619BE75Q42610772-CF241B42-E98A-4EDE-81F3-E3515B5EF041Q44729232-07457084-BB93-4968-B5F3-63E23824D8B6Q44927866-2734868B-7E4A-49CE-911B-18E92DD50BB6Q48388591-4895AD29-1E6D-49B8-A197-230A6C2767C0Q50527948-2EE82CEF-DDD1-4F70-A882-46AECD68DB32Q57587982-EA564253-9775-42B0-8424-BA85BBFD5A0BQ58124914-D7CD26BD-8EA0-4775-BFD6-9A1AD7561B01Q58256539-9B61765A-F1F1-4BFA-914D-904F2EE169E6Q58272555-7A3E3616-016B-468B-BDB8-5C653807E948Q58278688-ECBA7375-BC82-4026-B87B-99E7CA4ABF53
P2860
Characterization of a transthyretin (prealbumin) variant associated with familial amyloidotic polyneuropathy type II (Indiana/Swiss).
description
1986 nî lūn-bûn
@nan
1986 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
1986 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
1986年の論文
@ja
1986年論文
@yue
1986年論文
@zh-hant
1986年論文
@zh-hk
1986年論文
@zh-mo
1986年論文
@zh-tw
1986年论文
@wuu
name
Characterization of a transthy ...... pathy type II (Indiana/Swiss).
@ast
Characterization of a transthy ...... pathy type II (Indiana/Swiss).
@en
Characterization of a transthyretin
@nl
type
label
Characterization of a transthy ...... pathy type II (Indiana/Swiss).
@ast
Characterization of a transthy ...... pathy type II (Indiana/Swiss).
@en
Characterization of a transthyretin
@nl
prefLabel
Characterization of a transthy ...... pathy type II (Indiana/Swiss).
@ast
Characterization of a transthy ...... pathy type II (Indiana/Swiss).
@en
Characterization of a transthyretin
@nl
P2860
P356
P1476
Characterization of a transthy ...... pathy type II (Indiana/Swiss).
@en
P2093
F E Dwulet
M D Benson
P2860
P304
P356
10.1172/JCI112675
P407
P577
1986-10-01T00:00:00Z